CHEK1 and cancer: Recent studies show that inhibition of key RS response kinases such as ATR, Chk1, or Wee1—which cancer cells depend on to survive under RS—can tip the balance toward mitotic catastrophe, especially when combined with genotoxic therapy or in tumors with high intrinsic RS [32,33].